文献速递外周动脉疾病

外周动脉疾病致大截肢:18年血运重建与死亡率趋势

Peripheral Artery Disease Leading to Major Amputation: Trends in Revascularization and Mortality Over 18 Years.
PubMed 文献 · Ann Vasc Surg · 2021-06-25

该回顾性研究分析2000至2017年间312例因PAD行大截肢患者的血运重建类型与30天死亡率。结果显示血运重建向腔内治疗转变,膝上截肢死亡率显著高于膝下,且死亡率随年份略有上升。

要点

  • 大截肢前血运重建向腔内治疗转变,开放手术比例下降。
  • 膝上/经膝截肢30天死亡率27.7%,显著高于膝下8.9%。
  • 膝下动脉血运重建后截肢时间更短(中位2.1个月)。

核心结论

  • 过去20年大截肢后死亡率仍高,尤其是膝上/经膝截肢。
  • PAD患者大截肢前血运重建明显向腔内治疗转变。
  • 需膝下动脉血运重建的患者截肢更早,且多年无改善。

研究设计与样本

  • 回顾性分析2000年1月至2017年12月单中心连续因PAD行大截肢的患者。
  • 共312例患者(65.7%男性,平均年龄73.3±11岁),338次大截肢。

主要发现

  • 截肢前中位血运重建次数为2次(IQR 1-4),从2000至2017年每年轻微下降1.4%(IRR 0.986,95%CI 0.974-0.998,P=0.021)。
  • 16%(53/338)患者未行血运重建直接截肢,该比例在研究期间保持稳定。
  • 单纯开放治疗比例从2006年35%降至2016年0%,单纯腔内治疗从2002年17%增至2016年64%。
  • 首次血运重建为主动脉髂或股腘动脉者中位截肢时间9.5个月(IQR 0.9-67.6),膝下动脉者为2.1个月(IQR 0.5-13.8),P<0.001。
  • 膝下截肢30天死亡率为8.9%(22/247),膝上/经膝为27.7%(18/65),调整OR 3.84(95%CI 1.74-8.54,P=0.001)。

关键数值与推荐

  • 膝上/经膝截肢与30天死亡率独立相关(调整OR 3.84,95%CI 1.74-8.54,P=0.001)。
  • 30天死亡率随研究期间略有上升(调整OR 1.09,95%CI 1.018-1.159,P=0.021)。
  • 较高ASA分级与死亡率相关(调整OR 2.65,95%CI 1.23-5.72,P=0.012)。

临床怎么用

  • 对需膝下动脉血运重建的患者应加强肢体 salvag 策略研究。
  • 膝上截肢患者术后30天死亡风险高,需强化围手术期管理。
  • 腔内治疗已成为大截肢前血运重建的主要方式。

局限性

  • 单中心回顾性设计可能限制外推性。
  • 未报告其他患者特征与死亡率的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with peripheral artery disease (PAD) are at risk for amputation. The aim of this study was to assess the type of revascularization prior to and the 30-day mortality rate after major amputation due to PAD. METHODS: Retrospective analysis of consecutive patients undergoing major amputation for PAD between 01/2000 and 12/2017 at a tertiary referral center. The number and target level of ipsilateral revascularizations prior to amputation were analyzed per patient and over the years. There were 3 types of revascularization (open, endovascular and combined treatment) at 3 levels: aortoiliac, femoropopliteal and infrapopliteal. Univariate and multivariate logistic regression models were used to assess the association of level of amputation and patient characteristics with 30-day mortality. RESULTS: A total of 312 patients (65.7% male) with a mean age of 73.3 ± 11 years underwent 338 major amputations: 70 (21%) above/through knee and 268 (79%) below knee. A median of 2 (interquartile range, IQR 1-4) revascularizations were performed prior to amputation, with a slight decrease of 1.4% per year from 2000-2017 (incidence rate ratio of 0.986 0.974-0.998; Poisson regression analysis, P = 0.021). 16% (53/338) of patients underwent primary amputation without revascularization; this number remained relatively stable throughout the study period. The proportion of exclusively open treatment before amputation decreased substantially from 35% in 2006 to none in 2016, while exclusively endovascular revascularizations were performed increasingly from 17% in 2002 to 64% in 2016. Amputation occurred after a median of 9.5 months (IQR 0.9-67.6 months) if the first revascularization was aortoiliac or femoropopliteal and after 2.1 months (IQR 0.5-13.8 months) if the first intervention was infrapopliteal (P < 0.001) with no significant change over the years (normal linear regression, P= 0.887). Thirty-day mortality was 8.9% (22/247) after below knee and 27.7% (18/65) after above/through knee amputation (adjusted OR 3.84, 95% CI 1.74-8.54, P= 0.001) with a slight increase of mortality over the study period (adjusted OR 1.09, 95% CI 1.018-1.159, Poisson regression analysis, P= 0.021). The uni- and multivariate analysis of patient characteristics did not show an association with mortality, except higher ASA classification (adjusted OR 2.65, 95% CI 1.23-5.72, P= 0.012). CONCLUSIONS: Mortality, especially after above/through knee amputation, remains high over the past 2 decades. There is a clear shift towards endovascular treatment of patients with PAD prior to major amputation. In patients needing infrapopliteal revascularizations, amputation was performed much sooner than in those with aortoiliac or femoropopliteal interventions, with no improvement over the years. Strategies to extend limb salvage in these patients should be the focus of further research.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Abry L, Weiss S, Makaloski V, et al. Peripheral Artery Disease Leading to Major Amputation: Trends in Revascularization and Mortality Over 18 Years. Ann Vasc Surg. 2021. PMID: 34182110. doi:10.1016/j.avsg.2021.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。